About Terminal nucleotidyltransferase 5A
Terminal nucleotidyltransferase 5A (TENT5A) is a protein
from Homo sapiens identified by UniProt accession
Q96IP4, 442 residues long.
MolForge cross-references it against 0 known binders and
437 disease associations.
Target properties
| Protein name | Terminal nucleotidyltransferase 5A |
| UniProt accession | Q96IP4 |
| Gene | TENT5A |
| Organism | Homo sapiens |
| Length | 442 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (437)
Diseases linked to this target (Open Targets).
- body height · score 0.50
- osteogenesis imperfecta · score 0.48
- cystatin C measurement · score 0.45
- neutrophil count · score 0.44
- basophil count · score 0.43
- monocyte percentage of leukocytes · score 0.42
- refractive error measurement · score 0.42
- monocyte count · score 0.41
- BMI-adjusted waist-hip ratio · score 0.40
- neutrophil percentage of leukocytes · score 0.40
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96IP4-F1 | alphafold | PREDICTED | 79.57 | — |
Amino-acid sequence (442 residues)
MAEGEGYFAM SEDELACSPY IPLGGDFGGG DFGGGDFGGG DFGGGGSFGG HCLDYCESPT AHCNVLNWEQ VQRLDGILSE TIPIHGRGNF PTLELQPSLI VKVVRRRLAE KRIGVRDVRL NGSAASHVLH QDSGLGYKDL DLIFCADLRG EGEFQTVKDV VLDCLLDFLP EGVNKEKITP LTLKEAYVQK MVKVCNDSDR WSLISLSNNS GKNVELKFVD SLRRQFEFSV DSFQIKLDSL LLFYECSENP MTETFHPTII GESVYGDFQE AFDHLCNKII ATRNPEEIRG GGLLKYCNLL VRGFRPASDE IKTLQRYMCS RFFIDFSDIG EQQRKLESYL QNHFVGLEDR KYEYLMTLHG VVNESTVCLM GHERRQTLNL ITMLAIRVLA DQNVIPNVAN VTCYYQPAPY VADANFSNYY IAQVQPVFTC QQQTYSTWLP CN
Explore Terminal nucleotidyltransferase 5A with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets